Show simple item record

dc.contributor.authorRusso, Shirley M.
dc.contributor.authorPepe, Joyce A.
dc.contributor.authorCable, Edward Earl
dc.contributor.authorLambrecht, Richard W.
dc.contributor.authorBonkovsky, Herbert L.
dc.date2022-08-11T08:08:47.000
dc.date.accessioned2022-08-23T16:08:36Z
dc.date.available2022-08-23T16:08:36Z
dc.date.issued1994-06-01
dc.date.submitted2008-12-09
dc.identifier.citation<p>Eur J Clin Invest. 1994 Jun;24(6):406-15.</p>
dc.identifier.issn0014-2972 (Print)
dc.identifier.doi10.1111/j.1365-2362.1994.tb02184.x
dc.identifier.pmid7957494
dc.identifier.urihttp://hdl.handle.net/20.500.14038/32488
dc.description.abstractWe characterize a liver cell culture model for acute hepatic porphyrias that recapitulates the biochemical features of the human syndrome. In chick embryo liver cells in primary culture exposed to glutethimide and 4,6-dioxoheptanoic acid, heme alone produced a transient dose-dependent decrease in delta-aminolevulinate synthase and a concomitant increase in heme oxygenase. The addition of low concentrations of zinc-mesoporphyrin (50-200 nM), an inhibitor of heme oxygenase, led to more prolonged decreases in activity of the synthase and to an additive effect with heme. These effects of zinc-mesoporphyrin were associated with prolonged inhibition of heme oxygenase. These results suggest that the treatment of choice of acute porphyric syndromes may be the combination of low doses of heme and zinc-mesoporphyrin or another similarly non-toxic inhibitor of heme oxygenase.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=7957494&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://doi.org/10.1111/j.1365-2362.1994.tb02184.x
dc.subject5-Aminolevulinate Synthetase; Animals; Cells, Cultured; Chick Embryo; Dose-Response Relationship, Drug; Enzyme Repression; Ferric Compounds; Glutethimide; Heme; Heme Oxygenase (Decyclizing); Heptanoates; Kinetics; Liver; Metalloporphyrins; Nitrilotriacetic Acid; Porphyrias
dc.subjectLife Sciences
dc.subjectMedicine and Health Sciences
dc.titleRepression of ALA synthase by heme and zinc-mesoporphyrin in a chick embryo liver cell culture model of acute porphyria
dc.typeJournal Article
dc.source.journaltitleEuropean journal of clinical investigation
dc.source.volume24
dc.source.issue6
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/gsbs_sp/1057
dc.identifier.contextkey678822
html.description.abstract<p>We characterize a liver cell culture model for acute hepatic porphyrias that recapitulates the biochemical features of the human syndrome. In chick embryo liver cells in primary culture exposed to glutethimide and 4,6-dioxoheptanoic acid, heme alone produced a transient dose-dependent decrease in delta-aminolevulinate synthase and a concomitant increase in heme oxygenase. The addition of low concentrations of zinc-mesoporphyrin (50-200 nM), an inhibitor of heme oxygenase, led to more prolonged decreases in activity of the synthase and to an additive effect with heme. These effects of zinc-mesoporphyrin were associated with prolonged inhibition of heme oxygenase. These results suggest that the treatment of choice of acute porphyric syndromes may be the combination of low doses of heme and zinc-mesoporphyrin or another similarly non-toxic inhibitor of heme oxygenase.</p>
dc.identifier.submissionpathgsbs_sp/1057
dc.contributor.departmentDepartment of Medicine
dc.contributor.departmentGraduate School of Biomedical Sciences
dc.source.pages406-15


This item appears in the following Collection(s)

Show simple item record